These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8128940)

  • 1. Effect of heparin modeling on delivered hemodialysis therapy.
    Wei SS; Ellis PW; Magnusson MO; Paganini EP
    Am J Kidney Dis; 1994 Mar; 23(3):389-93. PubMed ID: 8128940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved dialyzer reuse after use of a population pharmacodynamic model to determine heparin doses.
    Ouseph R; Brier ME; Ward RA
    Am J Kidney Dis; 2000 Jan; 35(1):89-94. PubMed ID: 10620549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of hemodiafiltration to enhance delivered dialysis.
    Wei SS; Paganini EP; Cressman MD; Wright E
    ASAIO J; 1994; 40(4):977-80. PubMed ID: 7858335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Citrate compared to low molecular weight heparin anticoagulation in chronic hemodialysis patients.
    Janssen MJ; Deegens JK; Kapinga TH; Beukhof JR; Huijgens PC; van Loenen AC; van der Meulen J
    Kidney Int; 1996 Mar; 49(3):806-13. PubMed ID: 8648924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of coagulation and anti-Xa factor when using a heparin-coated AN69ST® dialyser.
    Sánchez-Canel JJ; Pons-Prades R; Salvetti ML; Seores A; Vázquez M; Pérez-Alba A; Tamarit E; Calvo-Gordo C; Villatoro J
    Nefrologia; 2012; 32(5):605-12. PubMed ID: 23013946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. National Kidney Foundation report on dialyzer reuse. Task Force on Reuse of Dialyzers, Council on Dialysis, National Kidney Foundation.
    Am J Kidney Dis; 1997 Dec; 30(6):859-71. PubMed ID: 9398135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dialyzer fiber bundle volume during hemodialysis using large-surface dialyzers.
    Leblanc M; Lafrance JP; Renald A
    ASAIO J; 2006; 52(6):646-51. PubMed ID: 17117054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of erythropoietin on dialyzer reuse, heparin need, and urea kinetics in maintenance hemodialysis patients.
    Veys N; Vanholder R; De Cuyper K; Ringoir S
    Am J Kidney Dis; 1994 Jan; 23(1):52-9. PubMed ID: 8285198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved preservation of residual renal function in chronic hemodialysis patients using polysulfone dialyzers.
    McCarthy JT; Jenson BM; Squillace DP; Williams AW
    Am J Kidney Dis; 1997 Apr; 29(4):576-83. PubMed ID: 9100048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is post-dialysis urea rebound significant with long slow hemodialysis?
    Jean G; Chazot C; Charra B; Terrat JC; Vanel T; Calemard E; Laurent G
    Blood Purif; 1998; 16(4):187-96. PubMed ID: 9736788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo effects of dialysate flow rate on Kt/V in maintenance hemodialysis patients.
    Hauk M; Kuhlmann MK; Riegel W; Köhler H
    Am J Kidney Dis; 2000 Jan; 35(1):105-11. PubMed ID: 10620551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increasing dialysate flow rate increases dialyzer urea clearance and dialysis efficiency: an in vivo study.
    Azar AT
    Saudi J Kidney Dis Transpl; 2009 Nov; 20(6):1023-9. PubMed ID: 19861865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eliminating the need for routine monthly postdialysis serum urea nitrogen measurement: A method for monitoring Kt/V and normalized protein catabolic rate using conductivity determined dialyzer clearance.
    Daugirdas JT
    Semin Dial; 2018 Nov; 31(6):633-636. PubMed ID: 30311270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urea kinetics with dialyzer reuse--a prospective study.
    Sridhar NR; Ferrand K; Reger D; Hayes P; Pinnavaia L; Butts D; Kohli R; Papandenatos G
    Am J Nephrol; 1999; 19(6):668-73. PubMed ID: 10592361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Middle molecule clearance does not influence protein intake in hemodialysis patients.
    Marcus RG; Cohl E; Uribarri J
    Am J Kidney Dis; 1998 Mar; 31(3):491-4. PubMed ID: 9506686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dialyzer Performance During Hemodialysis Without Systemic Anticoagulation Using a Heparin-Grafted Dialyzer Combined With a Citrate-Enriched Dialysate: Results of the Randomized Crossover Noninferiority EvoCit Study.
    François K; De Clerck D; Tonnelier A; Cambier ML; Orlando C; Jochmans K; Cools W; Wissing KM
    Am J Kidney Dis; 2022 Jan; 79(1):79-87.e1. PubMed ID: 33940113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodialysis using heparin-bound Hemophan in patients at risk of bleeding.
    Lee KB; Kim B; Lee YH; Yoon SJ; Kang WH; Huh W; Kim DJ; Oh HY; Kim YG
    Nephron Clin Pract; 2004; 97(1):c5-10. PubMed ID: 15153761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dialysate flow rate and delivered Kt/Vurea for dialyzers with enhanced dialysate flow distribution.
    Ward RA; Idoux JW; Hamdan H; Ouseph R; Depner TA; Golper TA
    Clin J Am Soc Nephrol; 2011 Sep; 6(9):2235-9. PubMed ID: 21799145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlates of urea kinetic modeling during hemodialysis in patients with acute renal failure.
    Jaber BL; King AJ; Cendoroglo M; Cunniff-Jaber PJ; Balakrishnan VS; Ruthazer R; Pereira BJ
    Blood Purif; 2002; 20(2):154-60. PubMed ID: 11818678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prescribing hemodialysis using a weekly urea mass balance model.
    Leypoldt JK; Kablitz C; Gregory MC; Senekjian HO; Cheung AK
    Blood Purif; 1991; 9(5-6):271-84. PubMed ID: 1819316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.